Scientists release data on potential new treatment targets for malaria – International collaboration led by St. Jude Children’s Research Hospital scientists identifies promising compounds for anti-malarial drug development and launches a database to share findings, advance fight against a leading killer of the world’s children
Success against malaria bolsters case for further investment, new report shows — World Vision cites analysis released today by Roll Back Malaria Partnership. – A new study linking funding increases in the global fight against malaria to a drop in deaths from the disease also shows that resources from donor governments still fall short of those needed for maximum impact against the world’s fourth-biggest killer of children, according to a global health policy analyst at international aid agency World Vision.
Study examines family lineage of King Tut, his possible cause of death – Malaria and bone abnormalities appear to have contributed to the death of Egyptian pharaoh King Tutankhamun, revealed by researchers.
Quantifying the number of pregnancies at risk of malaria in 2007: A demographic study – Research published this week in PLoS Medicine concludes that at least 125.2 million women at risk of malaria become pregnant each year.
Promising candidates for malaria vaccine revealed – Walter and Eliza Hall Institute researchers have uncovered a group of proteins that could form the basis of an effective vaccine against malaria.
Measuring and modeling blood flow in malaria — Fluid Dynamics Conference in Minneapolis highlights – When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells.
Gates Foundation funds development of coffee ring stain diagnostic test for malaria – The US’ Gates Foundation funds development of coffee ring stain diagnostic test for malaria. Vanderbilt University received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.
Threat of resistance to artemisinin-based anti-malarial drugs highlighted by new study – Malaria parasites in western Cambodia have become resistant to artemisinin based therapies, the first-line treatment for malaria, revealed by researchers.
New lead on malaria treatment – Variation of natural compound cures malaria in mice. – Approximately 350 million to 500 million cases of malaria are diagnosed each year mostly in sub-Saharan Africa. While medications to prevent and treat malaria do exist, the demand for new treatments is on the rise, in part, because malaria parasites have developed a resistance to existing medications.
Ranbaxy commences phase-iii clinical trials for its new anti-malarial molecule. The drug aims to transform the treatment of malaria in developing countries. – Ranbaxy Laboratories Limited (Ranbaxy) announced the commencement of Phase-III clinical trials for its new Anti-malaria combination drug, Arterolane maleate + Piperaquine phosphate in India, Bangladesh and Thailand.